Zacks Investment Research on MSN
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
UBS lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $546 from $553 and keeps a Buy rating on the shares. Published first on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback